Epizyme Inc (NASDAQ:EPZM)

15.00
Delayed Data
As of Jun 21
 -0.90 / -5.66%
Today’s Change
11.15
Today|||52-Week Range
21.40
+19.52%
Year-to-Date
No recent news for Epizyme Inc.

Today’s Trading

Previous close15.90
Today’s open15.95
Day’s range14.95 - 15.95
Volume328,065
Average volume (3 months)429,076
Market cap$1.1B
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-12.95%
Earnings growth (this year)-0.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+24.89%
P/E ratioNM
Price/Sales77.15
Price/Book4.71

Competitors

----
SGMOSangamo Therapeutics...-1.93-10.66%
RTRXRetrophin Inc-0.40-1.43%
FPRXFive Prime Therapeut...-0.55-3.11%
Data as of 4:00pm ET, 06/21/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$10.0M
Annual profit (last year)-$134.3M
Net profit margin-1,343.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts